Patents by Inventor Rhett Schiffman

Rhett Schiffman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CARBACHOL FORMULATIONS TO ENHANCE ANTI-PRESBYOPIA EFFECTS
    Publication number: 20240100009
    Abstract: The present disclosure is directed to ophthalmic formulations comprising carbachol, processes for preparing ophthalmic formulations comprising carbachol, and methods of treating presbyopia and other ophthalmic conditions by administering ophthalmic formulations comprising carbachol to a subject in need thereof.
    Type: Application
    Filed: December 6, 2023
    Publication date: March 28, 2024
    Inventors: Rhett SCHIFFMAN, Bruce FIRESTONE
  • IMPLANT FOR TREATMENT OF AN OCULAR CONDITION
    Publication number: 20230190643
    Abstract: The present disclosure relates to the field of pharmaceutical compositions, ocular implants, and systems and methods for treating an ocular condition. In certain aspects, the disclosure provides ocular implant systems for treating post-operative inflammation. In certain aspects, the ocular implants taught herein are rapid release extended treatment implants.
    Type: Application
    Filed: July 19, 2022
    Publication date: June 22, 2023
    Inventors: Andres Garcia, Rozemarijn Suzanne Verhoeven, Tomas Navratil, Rhett Schiffman
  • CYCLOSPORIN COMPOSITIONS
    Publication number: 20220409693
    Abstract: Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.
    Type: Application
    Filed: May 12, 2022
    Publication date: December 29, 2022
    Inventors: Richard S. Graham, Walter L. Tien, Mayssa Attar, Rhett Schiffman, Aileen Morgan
  • OCULAR IMPLANT AND DELIVERY SYSTEM
    Publication number: 20210030590
    Abstract: An ocular implant including a drug releasing element and having an inlet portion and a Schlemm's canal portion distal to the inlet portion, the inlet portion being disposed at a proximal end of the implant and sized and configured to be placed within an anterior chamber of a human eye, the Schlemm's canal portion being arranged and configured to be disposed within Schlemm's canal of the eye when the inlet portion is disposed in the anterior chamber.
    Type: Application
    Filed: February 19, 2019
    Publication date: February 4, 2021
    Applicant: Ivantis, Inc.
    Inventors: Wendy Blanda, Rhett Schiffman
  • Preservative free bimatoprost and timolol solutions
    Patent number: 10058560
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intraocular pressure and treatment of glaucoma.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: August 28, 2018
    Assignee: ALLERGAN, INC.
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • PRESERVATIVE FREE BIMATOPROST AND TIMOLOL SOLUTIONS
    Publication number: 20180185385
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intraocular pressure and treatment of glaucoma.
    Type: Application
    Filed: August 15, 2017
    Publication date: July 5, 2018
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • IMPLANT FOR TREATMENT OF AN OCULAR CONDITION
    Publication number: 20180177718
    Abstract: The present disclosure relates to the field of pharmaceutical compositions, ocular implants, and systems and methods for treating an ocular condition. In certain aspects, the disclosure provides ocular implant systems for treating post-operative inflammation. In certain aspects, the ocular implants taught herein are rapid release extended treatment implants.
    Type: Application
    Filed: May 27, 2016
    Publication date: June 28, 2018
    Inventors: Andres Garcia, Rozemarijn Suzanne Verhoeven, Tomas Navratil, Rhett Schiffman
  • Prevention and treatment of ocular side effects with a cyclosporin
    Patent number: 9839667
    Abstract: The present disclosure relates to methods of treatment or prevention of ocular conditions caused by treatment with certain therapeutically active agents. The methods can include administering a cyclosporine, an analog or derivative thereof, or a combination thereof to an eye of a mammal suffering from an ocular condition cased by treatment with certain therapeutically active agents, which can include a chemotherapy agent or an antiviral agent.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: December 12, 2017
    Assignee: Allergan, Inc.
    Inventors: Gregg Feinerman, Neil Barth, Rhett Schiffman, Pamela S. Barnett
  • Preservative free bimatoprost and timolol solutions
    Patent number: 9763958
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intra-ocular pressure and treatment of glaucoma.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: September 19, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • Cyclosporin compositions
    Patent number: 9561178
    Abstract: Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: February 7, 2017
    Assignee: Allergan, Inc.
    Inventors: Richard S. Graham, Walter L. Tien, Mayssa Attar, Rhett Schiffman, Aileen Morgan
  • PRESERVATIVE FREE BIMATOPROST AND TIMOLOL SOLUTIONS
    Publication number: 20150224115
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intra-ocular pressure and treatment of glaucoma.
    Type: Application
    Filed: April 21, 2015
    Publication date: August 13, 2015
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • Preservative free bimatoprost and timolol solutions
    Patent number: 9061034
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intra-ocular pressure and treatment of glaucoma.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: June 23, 2015
    Assignee: Allergan, Inc.
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • PRESERVATIVE FREE BIMATOPROST AND TIMOLOL SOLUTIONS
    Publication number: 20140256726
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intra-ocular pressure and treatment of glaucoma.
    Type: Application
    Filed: March 5, 2013
    Publication date: September 11, 2014
    Applicant: ALLERGAN, INC.
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN
    Publication number: 20140038904
    Abstract: Therapeutic methods are disclosed herein.
    Type: Application
    Filed: August 2, 2013
    Publication date: February 6, 2014
    Inventors: Gregg Feinerman, Neil Barth, Rhett Schiffman, Pamela S. Barnett
  • PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN
    Publication number: 20140038905
    Abstract: Therapeutic methods are disclosed herein.
    Type: Application
    Filed: August 2, 2013
    Publication date: February 6, 2014
    Inventors: Gregg Feinerman, Neil Barth, Rhett Schiffman, Pamela S. Barnett
  • PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN
    Publication number: 20140030226
    Abstract: Therapeutic methods are disclosed herein.
    Type: Application
    Filed: August 2, 2013
    Publication date: January 30, 2014
    Inventors: Gregg Feinerman, Neil Barth, Rhett Schiffman, Pamela S. Barnett
  • PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN
    Publication number: 20140010846
    Abstract: Therapeutic methods are disclosed herein.
    Type: Application
    Filed: August 14, 2013
    Publication date: January 9, 2014
    Applicant: Allergan, Inc.
    Inventors: Gregg Feinerman, Neil Barth, Rhett Schiffman, Pamela S. Barnett
  • PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN
    Publication number: 20140011751
    Abstract: Therapeutic methods are disclosed herein.
    Type: Application
    Filed: August 14, 2013
    Publication date: January 9, 2014
    Inventors: Gregg Feinerman, Neil Barth, Rhett Schiffman, Pamela S. Barnett
  • PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN
    Publication number: 20140011750
    Abstract: Therapeutic methods are disclosed herein.
    Type: Application
    Filed: August 2, 2013
    Publication date: January 9, 2014
    Inventors: Gregg Feinerman, Neil Barth, Rhett Schiffman, Pamela S. Barnett
  • PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN
    Publication number: 20140011752
    Abstract: Therapeutic methods are disclosed herein.
    Type: Application
    Filed: August 14, 2013
    Publication date: January 9, 2014
    Applicant: Allergan, Inc.
    Inventors: Gregg Feinerman, Neil Barth, Rhett Schiffman, Pamela S. Barnett